rs59896146
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_017950.4(CCDC40):c.2785G>A(p.Gly929Ser) variant causes a missense change. The variant allele was found at a frequency of 0.000419 in 1,614,230 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G929A) has been classified as Uncertain significance.
Frequency
Consequence
NM_017950.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CCDC40 | NM_017950.4 | c.2785G>A | p.Gly929Ser | missense_variant | 17/20 | ENST00000397545.9 | |
CCDC40 | NM_001243342.2 | c.2785G>A | p.Gly929Ser | missense_variant | 17/18 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CCDC40 | ENST00000397545.9 | c.2785G>A | p.Gly929Ser | missense_variant | 17/20 | 5 | NM_017950.4 | P2 |
Frequencies
GnomAD3 genomes AF: 0.00236 AC: 359AN: 152266Hom.: 3 Cov.: 32
GnomAD3 exomes AF: 0.000565 AC: 141AN: 249542Hom.: 3 AF XY: 0.000436 AC XY: 59AN XY: 135406
GnomAD4 exome AF: 0.000217 AC: 317AN: 1461846Hom.: 4 Cov.: 32 AF XY: 0.000188 AC XY: 137AN XY: 727220
GnomAD4 genome AF: 0.00236 AC: 359AN: 152384Hom.: 3 Cov.: 32 AF XY: 0.00223 AC XY: 166AN XY: 74520
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Benign:2
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 06, 2017 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 04, 2024 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at